"Our integration with VolparaDensity extends our capabilities and enables us to provide a more complete women's healthcare software suite," said
Cleared by the
"Creating an objective, reproducible value within the RIS/PACS workflow is critical, not only for efficiency in practice, but for meeting the demands of new breast density legislation," explains
Studies have shown traditional FFDM is only 48% effective in women with dense breasts, who also happen to be more susceptible to cancer. The estimated 40% of women in the U.S. who have dense breasts may benefit from adjunctive imaging modalities, such as ultrasound, MRI or molecular breast imaging, which can provide a clearer view of potential "hidden" cancers.
With the Viztek and Matakina partnership, smooth RIS/PACS integration of density data provides a significant increase in efficiency and also will aid in objectivity. The VolparaDensity output is done via the secondary capture to the Viztek Opal-PACS and structured report to the Opal-wRIS. The RIS will then take the data and put it automatically into the patient "lay letter" for mammography reporting functionality and streamlined workflow for the facility.
"We're helping doctors make good decisions, and we're the first in the industry to include density determination as part of a comprehensive plan," says Deaton. "It's the future of breast care and Viztek is leading the way."
Viztek is a leading provider of complete digital software and hardware imaging solutions, backed by comprehensive training and support for the hospital and private practice markets. The company provides state-of-the-art, web-based Opal-RAD PACS and RIS, delivering advanced connectivity and functionality at an affordable price. The PACS and RIS solutions are complimented by Viztek's comprehensive line of CR and DR solutions, with DR panels that come in multiple configurations ranging from retrofit packages to complete new radiology rooms and mobile solutions. For more information, visit www.viztek.net.
Founded to enable radiologists to give women the most accurate information possible regarding their breast health,
For media inquiries, contact
Brittny Quinn203-504-8230 x134 Email Contact